Uniting Research Capabilities
to Open the Future of Innovation

Advancing Innovation Through Collaboration

Welcome to the National Unit for Full-Stage Development of Immune Cell Gene Therapy (NDIT).

Thank you for visiting our website.

NDIT was established to accelerate the development of innovative immune cell gene therapies for solid tumors. By supporting the full-stage development of next-generation cell therapies—including CAR-T, TCR-T, and TIL—we are dedicated to translating promising scientific discoveries into life-changing treatments for patients.

As a national R&D initiative supported by multiple government ministries, NDIT bridges the gap between basic science and clinical medicine. We bring together researchers, clinicians, and other experts across Industry, Academia, Research Institutes, and Hospitals to build a powerful collaborative ecosystem. By sharing expertise and aligning our goals, we aim to drive breakthrough innovations and strengthen Korea's global capabilities in advanced biotherapies.

We will continue to foster collaboration, support pioneering research, and contribute to the development of safe and effective therapies that bring new hope to patients and their families.
Thank you for your continued interest and support.

Hyun Seok Um

Head, National Unit for Full-Stage Development of Immune Cell Gene Therapy (NDIT)